ArticleActa pharmacologica Sinica2024

A novel FAK-degrading PROTAC molecule exhibited both anti-tumor activities and efficient MDR reversal effects.

Ming-Shi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.